Significance Schizophrenia and bipolar disorder are psychiatric syndromes with a significant social and economic burden that share a common symptom, psychosis, attributed to excessive dopamine release. Despite years of intensive research, the causes of these devastating diseases are still unknown. In this work, a mouse line with a selective deletion of the molecular target of antipsychotics, dopamine D 2 receptors, from the most affected neuron subtype in patients, parvalbumin interneurons, results in animals with schizophrenia-like phenotypes and resistance to the broadly used antipsychotic aripiprazole. Therefore, this genetic dissection provides clues about the intrinsic molecular mechanism leading to a dysregulated dopamine system and the development of psychiatric conditions like schizophrenia, bringing opportunities to develop diagnostic and treatment approaches.
No takes yet. Share an insight, caveat, or question.
Tomasella et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: